Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Constantin Fühner"'
Autor:
Florian Janisch, Christina Kienapfel, Constantin Fühner, Thomas Klotzbücher, Phillip Marks, Tobias Hillemacher, Christian P. Meyer, Takehiro Iwata, Mehdi Kardoust Parizi, Guido Sauter, Margit Fisch, Shahrokh F. Shariat, Roland Dahlem, Michael Rink
Publikováno v:
Frontiers in Surgery, Vol 8 (2021)
Background: Sarcomatoid differentiation/histology of renal cell carcinoma (sRCC) in patients with metastatic renal cell carcinoma (mRCC) is still underresearched in current therapy regimes. We aimed to evaluate the impact of sRCC on outcomes in patie
Externí odkaz:
https://doaj.org/article/46f83ba3e8464463b86b544dabfebe2d
Autor:
Philipp Gild, Shahrokh F. Shariat, Florian Janisch, Roland Dahlem, Phillip Marks, Constantin Fühner, Christian Meyer, Michael Rink, Margit Fisch
Publikováno v:
Journal of Urology. 206
Autor:
Constantin Fühner, Florian Janisch, Phillip Marks, Michael Rink, Christian Meyer, Shahrokh F. Shariat, Margit Fisch, Roland Dahlem, Hang Yu, Jordan Mohammad Abufaraj Amman
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Differential risk stratification between the MSKCC and the IMDC prognostic score represents a clinical challenge regarding treatment decision-making and subsequently may ...
Autor:
Shahrokh F. Shariat, Christina Kienapfel, Roland Dahlem, Thomas Klotzbücher, Florian Janisch, Tobias Hillemacher, Michael Rink, Margit Fisch, Christian Meyer, Malte W. Vetterlein, Constantin Fühner
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:While cytoreductive nephrectomy (CN) was standard of care for a decade, the results of the CARMENA trial have challenged the role of CN in the multi-kinase receptor inhi...
Autor:
Constantin Fühner, Michael Rink, Florian Janisch, Thomas Klotzbücher, Christian Meyer, Christina Kienapfel, Shahrokh F. Shariat, Roland Dahlem, Margit Fisch, Tobias Hillemacher, Phillip Marks
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:The introduction of tyrosine-kinase inhibitors (TKI) fundamentally changed the natural history and outcomes of patients with metastatic renal-cell cancer (mRCC). Clear c...